1,468
Views
4
CrossRef citations to date
0
Altmetric
Hematology

Healthcare resource use and direct costs in severe aplastic anemia (SAA) patients before and after treatment with eltrombopag

, , , &
Pages 243-251 | Received 30 Jul 2019, Accepted 09 Oct 2019, Published online: 20 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meixin Fang, Hua Song, Jingying Zhang, Sisi Li, Diying Shen & Yongmin Tang. (2021) Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study. Pediatric Hematology and Oncology 38:7, pages 633-646.
Read now

Articles from other publishers (3)

Ruixin Li, Ningling Wang, Xingxing Chai, Linhai Yang, Kangkang Liu, Hailong He, Shengyun Lin, Yan Yang, Jinsong Jia, Donghua Zhang, Yuemin Gong, Jinning Shi, Guangsheng He & Jianyong Li. (2023) Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world. Clinical and Experimental Medicine.
Crossref
Phillip Scheinberg. (2021) Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries. British Journal of Haematology 194:6, pages 954-969.
Crossref
Emma M. Groarke, Bhavisha A. Patel, Fernanda Gutierrez‐Rodrigues, Olga Rios, Jennifer Lotter, Daniela Baldoni, Annie St. Pierre, Ruba Shalhoub, Colin O. Wu, Danielle M. Townsley & Neal S. Young. (2021) Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia. British Journal of Haematology 192:3, pages 605-614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.